| Q40818348 | 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck |
| Q42822876 | 2-Methoxy-4-vinylphenol can induce cell cycle arrest by blocking the hyper-phosphorylation of retinoblastoma protein in benzo[a]pyrene-treated NIH3T3 cells |
| Q40791226 | 6p abnormalities and TNF-alpha over-expression in retinoblastoma cell line |
| Q46778634 | A case of synovial sarcoma with abnormal expression of the human retinoblastoma susceptibility gene |
| Q40771488 | A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias |
| Q38264475 | A contemporary view of neoplasms in children. The pathologist's perspective. |
| Q29618817 | A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma |
| Q41445534 | A null allele of esterase D is a marker for genetic events in retinoblastoma formation |
| Q35589883 | A sialic acid-specific O-acetylesterase in human erythrocytes: possible identity with esterase D, the genetic marker of retinoblastomas and Wilson disease |
| Q36414839 | A straightforward approach to isolate DNA sequences with potential linkage to the retinoblastoma locus |
| Q44023124 | Absence of rearrangement of proto-oncogene MET in 88 cases of myelodysplastic syndromes (MDS). |
| Q37016112 | Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product |
| Q27851809 | Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer |
| Q24310436 | Amplification of a DEAD box protein gene in retinoblastoma cell lines |
| Q36568051 | An immunohistochemical study of retinoblastoma gene product in normal, premalignant and malignant tissues of the uterine cervix |
| Q37686889 | An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases |
| Q36748190 | Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides |
| Q38255176 | Antibody mimetics: promising complementary agents to animal-sourced antibodies |
| Q34619840 | Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders |
| Q29620421 | Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product |
| Q30499785 | Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition |
| Q26822487 | Caffeic Acid phenethyl ester is a potential therapeutic agent for oral cancer |
| Q35740051 | Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. |
| Q36913495 | Caffeic acid phenethyl ester suppresses proliferation and survival of TW2.6 human oral cancer cells via inhibition of Akt signaling |
| Q40778155 | Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis |
| Q89081284 | Cancer-mutation network and the number and specificity of driver mutations |
| Q36931459 | Cellular and molecular mechanisms of chemically induced renal carcinogenesis |
| Q34660148 | Cellular and molecular mechanisms of multistep carcinogenesis: relevance to carcinogen risk assessment |
| Q37436706 | Characterization and Expression Analysis of a Retinoblastoma-Related Gene from Chinese Wild Vitis pseudoreticulata |
| Q41606528 | Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses |
| Q28768656 | Chemical carcinogens: a review of the science and its associated principles. U.S. Interagency Staff Group on Carcinogens |
| Q67927742 | Chemical induction of somatic gene mutations and chromosomal aberrations in lung fibroblasts of rats |
| Q39745164 | Chromosomal changes in secondary leukemias of childhood and young adulthood |
| Q41478688 | Chromosome 13 transfer provides evidence for regulation of RB1 protein expression |
| Q67667612 | Chromosome breakage in lymphocytes from members of cancer families showing autosomal dominant inheritance |
| Q38253608 | Classification of subpopulations of cells within human primary brain tumors by single cell gene expression profiling. |
| Q41904203 | Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer |
| Q40901870 | Colonic retinoblastoma protein and proliferation in cancer and non-cancer patients |
| Q39503696 | Contiguous gene syndromes: a component of recognizable syndromes |
| Q39814516 | Current concepts on the biology of neuroblastoma |
| Q77585716 | Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases |
| Q47883620 | DNA repair, genome stability and cancer: a historical perspective |
| Q68839535 | De novo complex autosomal translocation involving chromosomes 8, 13 and 15 in a girl with a sporadic retinoblastoma |
| Q72068640 | Decreased expression of DCC mRNA in human colorectal cancers |
| Q24304934 | Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product |
| Q52249489 | Deletion of a homeobox gene in myeloid leukemias with a deletion in chromosome 2. |
| Q34378874 | Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein |
| Q69901151 | Detection of submicroscopic deletions and a DNA polymorphism at the retinoblastoma locus |
| Q40793159 | Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice |
| Q34359802 | Discovery of structural alterations in solid tumor oligodendroglioma by single molecule analysis |
| Q39354630 | Dissecting Pin1 and phospho-pRb regulation. |
| Q37672340 | Early human embryos are naturally aneuploid-can that be corrected? |
| Q35816726 | Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein |
| Q93082245 | Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy |
| Q34495498 | Epigenetic regulation of apoptosis and cell cycle in osteosarcoma |
| Q35197544 | Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship |
| Q39494403 | Evolution of tumours and the impact of molecular oncology |
| Q52589510 | Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development. |
| Q41595912 | Expression and amplification of the N-myc gene in primary retinoblastoma |
| Q40894360 | Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma |
| Q47362424 | Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer |
| Q34253240 | Expression of the functional cone phototransduction cascade in retinoblastoma |
| Q21136078 | Expression of versican 3'-untranslated region modulates endogenous microRNA functions |
| Q53813775 | Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. |
| Q35895097 | From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing. |
| Q45248744 | Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes. |
| Q35218956 | Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells |
| Q38273682 | HIT family genes: FHIT but not PKCI-1/HINT produces altered transcripts in colorectal cancer. |
| Q39755276 | Hematopoietic growth and differentiation factors and the reversibility of malignancy: cell differentiation and by-passing of genetic defects in leukemia. |
| Q33674101 | High resolution gene mapping of the human alpha globin locus |
| Q28910466 | Homology between a region of the human retinoblastoma gene and L1 family repetitive sequences |
| Q69149581 | Homozygosity for 8pter----q22 in acute myeloblastic leukemia with t(8;21)(q22;q22) |
| Q30502375 | Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines |
| Q39668510 | Human cancer and cellular oncogenes |
| Q39580304 | Identification & Characterization of lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics |
| Q24568213 | Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation |
| Q29620442 | Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product |
| Q48236283 | Identification of target genes downstream of semaphorin6A/PlexinA2 signaling in zebrafish. |
| Q44959102 | Identifying differentially expressed genes in cancer patients using a non-parameter Ising model |
| Q73224117 | Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue |
| Q42793095 | Interleukin-2-dependent phosphorylation of the retinoblastoma-susceptibility-gene product p110-115RB in human T-cells |
| Q41918696 | Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells |
| Q39656160 | Involvement of E2F1 transcriptional activity in cadmium‐induced cell‐cycle arrest at G1 in human lung fibroblasts |
| Q38121090 | Is PML a Tumor Suppressor? |
| Q39743034 | Is spontaneous mutation the major 'cause' of childhood acute lymphoblastic leukaemia? |
| Q44752314 | Is your initiator really necessary? |
| Q35196851 | Loss of heterozygosity for alleles on chromosome II in cervical carcinoma |
| Q42818533 | Lunasin is prevalent in barley and is bioavailable and bioactive in in vivo and in vitro studies |
| Q92095622 | MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors |
| Q64109482 | MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research |
| Q36141200 | Mechanism of PAP I gene induction during hepatocarcinogenesis: clinical implications |
| Q53766889 | MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. |
| Q34354797 | MicroRNA-188 suppresses G1/S transition by targeting multiple cyclin/CDK complexes |
| Q35069781 | Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation |
| Q33931438 | Molecular cloning of lethal(2)giant larvae, a recessive oncogene of Drosophila melanogaster |
| Q24630136 | Molecular cloning of the human esterase D gene, a genetic marker of retinoblastoma |
| Q37401663 | Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas |
| Q39701871 | Molecular genetic approaches to the analysis of human ophthalmic disease |
| Q53541670 | Monosomy 7 and multipotential stem cell transformation. |
| Q36351161 | Multiple cancers. Tumor burden permits the outgrowth of other cancers |
| Q35200318 | New approaches to investigating heterogeneity in complex traits |
| Q36467625 | Non-ocular cancer in relatives of retinoblastoma patients |
| Q26823718 | Noncoding RNA in oncogenesis: a new era of identifying key players |
| Q50053626 | Notch signaling via regulation of RB and p-AKT but not PIK3CG contributes to MIA PaCa-2 cell growth and migration to affect pancreatic carcinogenesis |
| Q39553062 | Ocular and orbital tumors. |
| Q36874460 | Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour |
| Q33943421 | Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy |
| Q40367838 | Ophthalmology: recessive human cancer genes. |
| Q45905863 | Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study. |
| Q70545682 | Pathogenesis of colorectal cancer |
| Q34563696 | Patterns of risk of hereditary retinoblastoma and applications to genetic counselling |
| Q54746746 | Pigmented ocular fundus lesions in the inherited gastrointestinal polyposis syndromes and in hereditary nonpolyposis colorectal cancer. |
| Q74063486 | Primary and secondary osteosarcoma of the face: a rare childhood malignancy |
| Q35821807 | Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis |
| Q36458932 | RB116: an RB1+ retinoblastoma cell line expressing primitive markers. |
| Q37573667 | Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. |
| Q36050995 | Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases. |
| Q33646521 | Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival |
| Q39656468 | Retinoblastoma, chromosome abnormalities and oncogene expression |
| Q39620993 | Retinoblastoma-associated protein 140 as a candidate for a novel etiological gene to hypertension |
| Q42243934 | Retinoblastoma: A new challenge to the Knudson's Dogma |
| Q27021129 | Retinoblastoma: An overview |
| Q40781979 | Retinoblastoma: a review |
| Q34164134 | Review and hypotheses: somatic mosaicism: observations related to clinical genetics |
| Q86405868 | Role of MYCN in retinoblastoma |
| Q34318909 | Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells |
| Q34246832 | Role of the retinoblastoma gene in the initiation and progression of human cancer |
| Q35673992 | Schwann-like cell differentiation from rat bone marrow stem cells. |
| Q40833050 | Second malignancies following treatment in non-Hodgkin's lymphoma |
| Q73097589 | Second malignant neoplasms in children after treatment of soft tissue sarcoma |
| Q36027090 | Second primary neoplasms in patients with retinoblastoma |
| Q33562563 | Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology |
| Q36661628 | Some speculation on the origin of glioblastoma |
| Q34286617 | Specific chromosomal abnormalities characterize fibrosarcomas of bovine papillomavirus type 1 transgenic mice |
| Q41526922 | Strategies for Approaching Retinoblastoma Tumor Suppressor Gene Therapy |
| Q36506484 | Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10 |
| Q52091551 | The Perlman syndrome: Familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies |
| Q52337497 | The Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. 1984. |
| Q52390983 | The Temporal Regulation of S Phase Proteins During G1. |
| Q39401616 | The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). |
| Q39522957 | The cytogenetics of childhood leukemia: clinical and biologic implications |
| Q24299187 | The interleukin 3 gene is located on human chromosome 5 and is deleted in myeloid leukemias with a deletion of 5q |
| Q39345488 | The oxysterol receptors LXRα and LXRβ suppress proliferation in the colon. |
| Q36284134 | The pineal gland: A model for adrenergic modulation of ubiquitin ligases |
| Q34637442 | The process of leukemogenesis |
| Q24296000 | The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations |
| Q38015271 | The retinoblastoma gene: its role in human malignancies |
| Q38334818 | The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F |
| Q38962238 | The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness |
| Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
| Q40485390 | Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome |
| Q34658581 | Tumor suppressor genes in normal and malignant hematopoiesis |
| Q39783451 | Two further cases of t(2;13) in alveolar rhabdomyosarcoma indicating a review of the published chromosome breakpoints |
| Q52870340 | Types, rates, origin and expressivity of chromosome mutations involving 13q14 in retinoblastoma patients. |
| Q24604540 | Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy |
| Q39825010 | Use of cultured human tissues and cells in carcinogenesis research |
| Q37982819 | What getting sick means |
| Q37204601 | p120catenin alteration in cancer and its role in tumour invasion. |
| Q28260456 | pRb2/p130: a new candidate for retinoblastoma tumor formation |